Zenpep pancrelipase regulatory update

FDA approved an sNDA from Aptalis (formerly Axcan Pharma Inc.) for a 25,000 lipase unit formulation of Zenpep pancrelipase delayed-release capsules to treat exocrine pancreatic insufficiency (EPI) d...